Search
forResearch 10 of 1000+
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- An overview of management of drug-induced hair and nail disorders
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →